ServiziMenu principaleHome
You are here:  > Educational Opportunities > Past events > 2018 > 17th ESO-ESMO Masterclass in Clinical Oncology
Share on Share on Facebook Twitter Share on Linkedin Share on WhatsApp Share on Instagram Share by email Print this page


Chairs: N. Pavlidis, GR - R.A. Stahel, CH
Scientific Advisors: F. Lordick, DE - R. Popescu, CH

This clinically oriented educational programme has been designed for medical or clinical oncologists who wish to improve their skills or those who are preparing for the national board exam. The programme will expose participants to a full spectrum of issues in clinical oncology and to practice-oriented training. The programme focuses on breast, gastro-intestinal, lung, genito-urinary, gynaecological, head and neck cancers.
Workshops and spotlight sessions will facilitate compact update on communication skills, supporting and palliative care, immunotherapy, melanoma, sarcomas and GIST, treatment of elderly cancer patients, molecular tumour boards, magnitude of benefits scale, drug availability, biosimilars, adolescents and young adults, different roles in the oncology team, ethical dilemmas, low and high grade lymphomas.

The Masterclass offers plenary lectures regarding state-of-the-art clinical evaluation and treatments with reference to clinical guidelines and which will conclude in take-home messages. Participants will deliver case presentations within tumour boards and small groups and discuss them with the chairmen and the faculty. Informal discussion will be facilitated during the lunches with the experts and the networking aperitifs.
All participants will reside at the course venue and participation is compulsory throughout the whole course. The Masterclass will be entirely in English and fluency in English is necessary for admission. Participants of the concomitant Masterclass in Nursing Oncology will attend selected medical sessions whilst the communication skills and ethical dilemmas workshops will be attended jointly.

• A 5-day residential educational event
• Full immersion
• Clinically-oriented
• Multidisciplinary
• An international faculty of top experts delivering lectures focusing on genito-urinary, breast, gynaecological, head and neck, gastro-intestinal and lung cancers.

The Masterclass in
Clinical Oncology is an
ESO-ESMO joint event


The Masterclass is held
in collaboration with the
Flims Alumni Club


The 2018 Masterclass is part of
the Masterclass-Online Study
Program in Advanced Oncology
of the University of Ulm




M. Aapro, Clinique de Genolier, Oncology Dpt., Genolier, CH
M. Andreoletti
, European Institute of Oncology, Milano, IT

A. Arber, University of Surrey, Faculty of Health and Medical Sciences, Guildford, UK
G. Boniolo, University of Ferrara, Dept of Biomedical and Surgical Sciences, Ferrara, IT
l. Brugieres, Institut Gustave Roussy, Cancer in Young Adults, Paris, FR
P. Casali, National Cancer Institute, Medical Oncology Dpt., Milan, IT
F. Cavalli, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, CH
G. Curigliano, European Institute of Oncology, Department of Medicine, Division of Experimental Therapeutics, Milano, IT
A. Dietz, University Hospital Leipzig, ENT Department, Leipzig, DE
M. Dreyling, Munich University Hospital, Medical Clinic III, Munich, DE
A. Eniu, Cancer Institute "Ion Chiricuta", Dept. of Breast Cancer, Cluj-Napoca, RO
C. Faivre-Finn, The Christie and University of Manchester, Institute of Cancer Sciences, Manchester, UK
K. Fizazi, Institut Gustave Roussy, Dept. of Cancer Medicine, Villejuif, FR
W. Gatzemeier, Humanitas Cancer Center, Breast Unit, Rozzano, IT
S. Gillessen, Kantospital St. Gallen, Onco-Haematology Clinic, St Gallen, CH
S. Hillinger, University Hospital Zurich, Dept. of Thoracic Surgery, Zurich, CH
A. Hoy, Consultant in Palliative Medicine, Epsom, UK
F. Lordick, University Hospital Leipzig, University Cancer Center Leipzig, Leipzig, DE
M. Maio, Le Scotte Polyclinic, Siena, IT
P. Maugeri, University of Milan, Dept. of Experimental Oncology, Milan, IT
O. Michielin, Lausanne University Hospital - CHUV, Dept. of Medical Oncology, Lausanne, CH
R. Orecchia, European Institute of Oncology, Div. of Radiotherapy, Milan, IT
O. Pagani, Oncology Institute of Southern Switzerland (IOSI), Breast Unit, Bellizona, CH
N. Pavlidis, University Hospital of Ioannina, Div. of Medical Oncology, Ioannina, GR
S. Peters, Centre Hospitalier Universitaire Vaudois, Dept. of Oncology, Lausanne, GR
R. Popescu, Hirslanden Klinik Aarau, Tumor Center - Dept. of Medical Oncology, Aarau, CH
G. Pruneri, University of Milan – European Institute of Oncology, Dept. of Pathology - Biobank for Translational Medicine Dpt., Milano, IT
M. Roobol, Erasmus University Medical Center, Dept. of Urology, Rotterdam, NL
V. Sanchini, European Institute of Oncology, Dept. of Biomedical Humanities, Milan, IT
M. Schmidinger, Medical University of Vienna, Internal Medicine Clinic I - Dept. of Oncology, Vienna, AT
D. Sebag-Montefiore, University of Leeds and Leeds Cancer Centre, Dept. of Oncology, Leeds, UK
J. Sehouli, Charité Medical University, Gynaecological Clinic, Berlin, DE
C. Sessa, Oncology Institute of Southern Switzerland, Div. of Medical Oncology, Bellinzona, CH
R. Stahel, University Hospital Zurich, Cancer Center Zurich, Zurich, CH
E. Van Cutsem, University Hospital Leuven, Digestive Oncology Dpt., Leuven, BE
E. Van Muilekom, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Urology Dpt., Amsterdam, NL
J. Vermorken, Antwerp University Hospital, Dept. of Medical Oncology, Edegem, BE
C. Witt, University Hospital Zurich and University of Zurich, Inst. Complementary and Integrative Medicine, Zurich, CH

General information

ORGANISING SECRETARIAT                       
Francesca Marangoni                            
Ph: +39 02 85464525                           
Email: fmarangoni@eso.net                        
European School of Oncology
Via Turati, 29
20121 Milan, Italy
Fax: +39 02 85464545

Corinne Hall
Ph: +39 02 85464522
Email: chall@eso.net


The event has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS). The evaluation of the event has been performed by the Accreditation Council of Oncology in Europe (ACOE) that acknowledged the quality of the scientific programme and its educational value. The event is designated for a maximum of 31 European CME credits (ECMEC). Through an agreement between UEMS and the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™.
The Masterclass has been accredited with 25 Cat.1 ESMO MORA points.
The Masterclass has also received 47 points from the Landesärzteskammer Brandenburg (reserved to German participants).

The Masterclass is part of the Sharing Progress in Cancer Care programme whose sustaining members are (as of June 2017):
• Platinum member: Astrazeneca, BMS
• Gold members: Eli Lilly, Helsinn, Merck KGaA, Darmstadt, Germany, Pfizer and Roche
• Silver members: Boehringer Ingelheim, Celgene Corporation, Genomic Health, Novartis Oncology, Sandoz Biopharmaceutical

Follow updates, send questions and join in the discussions using #18MCO on Twitter and Facebook.


 24 March

    Participants' arrival, airport transfers, registration
 13:00   Lunch      
 14:00   Focus on ESO, ESMO and EONS
N. Pavlidis, GR - R. Stahel, CH - E. Van Muilekom, NL
14:30   Communication Skills Workshop - 2 Groups
A. Arber, UK - A. Hoy, UK       
14:30   Warm up + Case presentations by participants
R.A. Stahel, CH - R. Popescu, CH
  Coffee break
17:00   Communication Skills Workshop - 2 Groups 
A. Arber, UK - A. Hoy, UK
  Warm up + Case presentations by participants
N. Pavlidis, GR - F. Lordick, DEH
20:00   Dinner    


 25 March

 8:30   Clinical session Lung cancer   
Chair: R.A. Stahel, CH
S. Hillinger, CH   
C. Faivre-Finn, UK
Chemotherapy and targeted treatment    
R.A. Stahel, CH
Immunotherapy of thoracic malignancies   
S. Peters, CH
Small cell lung cancer   
C. Faivre-Finn, UK
Discussion after each lecture  
11:00   Coffee break  
 11:30   Tumour board Lung cancer    
R.A. Stahel, CH - S. Hillinger, CH - C. Faivre-Finn, UK - S. Peters, CH
 12:30   Spotlight session Body and mind   
C. Witt, CH      
 12:50   Discussion 
 13:00   Lunch with the expert
 14:00   Spotlight session Molecular tumour boards   
O. Michielin, CH
 14:30   Discussion   
 14:40   Spotlight session Gender issues   
S. Peters, CH
 15:00   Discussion
 15:10   Spotlight session Melanoma and introduction to immunotherapy
O. Michielin, CH
 15:40   Discussion
15:50   Spotlight session Case based management of immuno-oncology   
S. Peters, CH      
 16:30   Discussion   
 18:30   Networking Aperitif
 19:30   Dinner


 26 March

  Clinical session Gastro-intestinal tumours   
Chair: D. Sebag-Montefiore, UK  
    Systemic treatment in adjuvant setting in colon cancer   
E. van Cutsem, BE     
Systemic treatment in advanced colon cancer    
E. van Cutsem, BE
Management of rectal cancer (surgery and radiotherapy)   
D. Sebag-Montefiore, UK      
Systemic treatment in early and advanced gastric cancer   
F. Lordick, DE     
Pancreatic cancer   
R. Popescu, CH
Discussion after each session
11:00   Coffee break         
11:30   Tumour board Gastro-intestinal tumours    
D. Sebag-Montefiore, UK - E. van Cutsem, BE - R. Popescu, CH - F. Lordick, DE
12:30   Spotlight session Magnitude of benefits scale   
R.A. Stahel, CH
12:50   Discussion   
13:00   Lunch with the expert
13:50   Spotlight session Case based management of sarcomas and GIST
P. Casali, IT
 14:20   Discussion  
14:30   Spotlight session Adolescents and young adults   
L. Brugieres, FR
14:50   Discussion   
 15:00   Spotlight session Low and high grade lymphomas: recent therapeutic advances    
M. Dreyling, DE
 15:35   Discussion   
 15:45   Case presentations by participants (4 groups)
N. Pavlidis, GR - R.A. Stahel, CH - R. Popescu, CH - F. Lordick, DE
 18:30   Networking Aperitif      


 27 March

8:30   Clinical session Breast cancer (early and advanced)   
Chair: G. Curigliano, IT  
G. Pruneri, IT    
W. Gatzemeier, IT
R. Orecchia, IT      
Treatment of Luminal    
O. Pagani, CH
Treatment of HER-2+
A. Eniu, RO      
Treatment of triple negative   
G. Curigliano, IT
Discussion after each session
11:00   Coffee break        
11:30   Tumour board Breast cancer    
G. Curigliano, IT - O. Pagani, CH - W. Gatzemeier, IT - A. Eniu, RO - G. Pruneri, IT - R. Orecchia, IT
12:30   Spotlight session Case based management of elderly cancer patients   
M. Aapro, CH
12:50   Discussion   
13:00   Lunch with the expert
14:00   Spotlight session Case-based management of supportive and palliative care   
M. Aapro, CH  
14:20   Discussion 
14:30   Spotlight session Biosimilars and drug repositioning   
G. Curigliano, IT
14:50   Discussion
15:00   Introduction and presentation of the workshop    
G. Boniolo, IT 
15:20   Parallel sessions: Interactive workshop on ethical dilemmas (4 groups)   
G. Boniolo, IT - V. Sanchini, IT - P. Maugeri, IT - M. Andreoletti, IT        
16:00   Sum-up on ethical dilemmas (panel discussion)  
Groups representatives + moderators
 16:30   Discussion
 18:30   Networking Aperitif    
 19:30   Dinner + special evening    


 28 March

8:30   Clinical session Genito-urinary cancers   
Chair: K. Fizazi, FR
    Localized prostate cancer   
M. Roobol, NL
Treatment of metastatic castration sensitive prostate cancer   
S. Gillessen, CH      
Castration-resistant prostate cancer   
K. Fizazi, FR      
Metastatic renal cancer: evidence-based treatment   
M. Schmidinger, CH  
Germ cell   
K. Fizazi, FR
Treatment of bladder cancer
S. Gillessen, CH
Discussion after each session
11:30   Coffee break
12:00   Tumour board Genito-urinary cancers    
K. Fizazi, FR - S. Giellessen, CH - M. Roobol, NL - M. Schmidinger, CH
13:00   Lunch with the expert
 14:00   Clinical session Gynaecological cancers   
Chair: J.B. Vermorken, BE
J. Sehouli, DE
Ovarian cancer   

J.B. Vermorken, BE
Cervical and endometrial cancers
C. Sessa, CH
Discussion at the end of each lecture
 16:00   Tumour board Gynaecological cancers    
J.B. Vermorken, BE - C. Sessa, CH - J. Sehouli, DE
The evolving paradigm of clinical oncology and the role of biomarker technology in treatment today and in the future
M. Maio, IT
18:30   Networking Aperitif
19:30   Dinner


 29 March

 8:30   Learning assessment test  
 9:30   Clinical session Head and neck cancer   
Chair: Jan B. Vermorken, NL
    Prognostic factors and surgical approach  
A. Dietz, DE     
R. Orecchia, IT
Systemic therapy and radio- chemo-therapy   
J.B. Vermorken, NL
Discussion after each session
11:15   Coffee break
 11:45   Tumour board Head & Neck cancer
J.B. Vermorken, NL - R. Orecchia, IT - A. Dietz, DE
 12:15   Keynotes from the World Oncology Forum
F. Cavalli, CH
 12:50   Discussion
 12:45   Closing remarks